We were honored to have Kiran Krishnan - CEO of Microbiome labs present on our Tuesday webinar series.
I guarantee that you will learn things about your gut you did not know before. Importantly, as a microbiologist, Kiran has led key product advances at the Labs and he presents solutions to a myriad of gut-related disorders.
The microbiome's integrity is probably the most important aspect of health and you have great control over its integrity. However, maintaining a truly optimal gut is a life-long pursuit.
Your are what you absorb - not just what you eat.
My research has yielded the following information.
If you gut is not optimal, you preferentially absorb sugars. Thus if your gut is not optimal you are EATING JUNK FOOD even if it looks organic and healthy.
Measuring gut health is at its infancy. You can do various stool tests to get a gut profile. However, I look at blood parameters to develop a picture as to where you lie on the gut continuum. These markers include:
H-pylori IgG - from a blood test. The reference range for this biomarker is completely inadequate at explaining the risk of h-pylori
ESR - how fast your red blood cells settle. Minerals create the charge that keep red blood cells from settling - so if they settle, you are mineral deficient.
Homocysteine - By putting people on probiotics, I have seen HcY come down without any other treatment.
Iron and Ferritin - Iron is hard to absorb and the levels of these two give clues about absorption.
Even the big medical authorities are getting on the microbiome bandwagon. They cannot leave their heads in the sand for ever in the presence of compelling evidence of its importance. Here is a case-in-point article.
Importance The gut microbiome, home to the vast kingdom of diverse commensal bacteria and other microorganisms residing within the gut, was once thought to only have roles primarily centered on digestive functions. However, recent advances in sequencing technology have elucidated intricate roles of the gut microbiome in cancer development and efficacy of therapeutic response that need to be comprehensively addressed from a clinically translational angle.
Observations This review aims to highlight the current understanding of the association of the gut microbiome with the therapeutic response to immunotherapy, chemotherapy, radiotherapy, cancer surgery, and more, while also contextualizing possible synergistic strategies with the microbiome for tackling some of the most challenging tumors. It also provides insights on contemporary methods that target the microbiota and the current progression of findings being translated from bench to bedside.
Conclusions and Relevance Ultimately, the importance of gut bacteria in cancer therapy cannot be overstated in its potential for ushering in a new era of cancer treatments. With the understanding that the microbiome may play critical roles in the tumor microenvironment, holistic approaches that integrate microbiome-modulating treatments with biological, immune, cell-based, and surgical cancer therapies should be explored.
The link to the presentation:
The origin story of Microbiome Labs is a classic tale of forging new frontiers, complete with discovery, adversity, and a leap of faith. Neither founder set out on a path to start his own supplement company, but through persistent curiosity Dr. Tom Bayne and Microbiologist Kiran Krishnan stumbled upon an amazing opportunity.
With a rich background in research, Kiran noticed that many supplement companies were lacking sufficient clinical data, which inspired him to design trials that were more affordable and fitting for the supplement industry. He then expanded his skill set into product development and formulation for a number of retail supplement companies. Eventually he was hired to study probiotics and discover what would become the next big probiotic in the industry: Bacillus spores.
Before Kiran discovered the spores, Dr. Tom took a step back from supplement manufacturing and settled into his own chiropractic practice. As his practice began to blossom, he found himself on the forefront of Functional Medicine, uniquely focused on his patients’ gut health. For years, probiotics had proven so ineffective and inconsistent that he eventually quit using them in his practice altogether – that is, until he saw the research that Kiran had uncovered.
With Dr. Tom’s clinical expertise and Kiran’s probiotic research, the serendipitous pair formulated the first all-spore probiotic known as MegaSporeBiotic. After a great deal of clinical validation, the team set out to launch the product in the practitioner market by attending medical conferences.
In 2014, the company exhibited at only 6 conferences and signed on a handful of new accounts. However, as the product sales began to grow, the company chose to reallocate the majority of the profits back into research, with only a minimal amount leftover for marketing. This unorthodox approach is far and away what continues to set Microbiome Labs apart from the rest of the supplement industry.
In doing so, Microbiome Labs hopes to encourage other supplement companies to follow suit, thereby raising the bar of the supplement industry as a whole. In 2018, Microbiome Labs attended over 148 conferences, initiated and/or completed 14 clinical trials, and provided key solutions to thousands of practitioners, changing over 344,000 lives… and counting.
Weekly Webinar Links: Join us for some detailed health information - at not charge. All are welcome.
Monday at noon EST -
Tuesday at 8pm EST -
Be Bold - Be Brave - Stay Well